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Previewsmore about how HCMV regulates the cell
cycle during infection. The study repre-
sents an excellent example of how using
drugs in the laboratory can be beneficial,
and it is not out of the question that its
results might have implications for the
use of such drugs in the clinic.ACKNOWLEDGMENTS
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Pioneering plant research has shown that many Nod-like receptors (NLRs) detect pathogens indirectly via
recognizing modifications of other host proteins. In this issue, two groups show that the RPM1 NLR is acti-
vated by phosphorylation of the host protein RIN4, probably resulting from activation of a host kinase by
pathogen effectors.The innate immune systems of both
plants and animals employ intracellular
receptors of the NOD-like receptor (NLR)
family to detect the presence of patho-
gens. NLRs are characterized by the
presence of a central nucleotide binding
and oligomerization domain (NOD, often
referred to as a NACHT or NB-ARC
domain) and C-terminal leucine-rich
repeats (LRRs). The N-terminal domains
are more variable, and differ between
plant and animal NLRs. The human
genome encodes 22 predicted functional
NLR genes (http://www.genenames.org/
genefamily/nlr.php), and mutations in
several of these have been linked to
multiple autoinflammatory and immuno-
deficiency diseases (Inohara et al., 2005;
Schroder and Tschopp, 2010). Under-
standing how NLR proteins are activated
is thus of intense interest to both plant
and animal immunologists.Work on plant NLR signaling pathways
is contributing to our understanding of
mammalian NLR signaling, particularly
in understanding how NLR proteins
‘‘detect’’ pathogens. Several plant NLRs
have been shown to detect pathogen
proteins indirectly via sensing pathogen-
induced modifications of other host
proteins (DeYoung and Innes, 2006).
This has raised the question of whether
mammalian NLRs might also use such
indirect recognition mechanisms. Recent
work indicates that human NLRP3, which
is activated by a diverse array of pathogen
molecules, probably detects the pres-
ence of pathogens indirectly (Schroder
and Tschopp, 2010). The common
denominator among the diverse signals
that activate NLRP3 appears to be excess
production of reactive oxygen species
(ROS) by mitochondria (Zhou et al.,
2011). Elevated levels of ROS appear tobe ‘‘sensed’’ by thioredoxin (TRX)-inter-
acting protein (TXNIP), which binds to
NLRP3 in a ROS-dependent manner
(Zhou et al., 2010). Thus, in this example,
pathogens and other cellular stresses
are being sensed indirectly by detecting
the presence of free TXNIP released
from thioredoxin as a consequence of
elevated ROS. Whether other mammalian
NLRs use such indirect mechanisms of
detection remain to be determined, but
this seems likely given the diversity of
activators for most characterized NLRs
and the complete absence of evidence
for direct binding of known activators to
their corresponding NLRs.
Among plant NLRs, arguably the best
characterized is the RPM1 protein of
Arabidopsis. RPM1 is activated by at least
two different effector proteins from Pseu-
domonas syringae, AvrB and AvrRpm1.
Activation of RPM1 by either of these, February 17, 2011 ª2011 Elsevier Inc. 87
Figure 1. Two Models for Activation of Arabidopsis RPM1 by the P. syringae Effector AvrB
The work of Chung et al. and Liu et al. demonstrate that phosphorylation of RIN4 on threonine 166 activates RPM1 signaling, activating defense responses. In
(A), preferred by Liu et al., RIN4 is phosphorylated by the host kinase RIPK, which is activated by AvrB. In (B), RIPK phosphorylates AvrB, which then phosphor-
ylates RIN4.
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of a second Arabidopsis protein, RIN4. It
has been known for some time that AvrB
and AvrRpm1 physically associate with
RIN4 inside plant cells and that they
induce phosphorylation of RIN4 (Mackey
et al., 2002). However, it has remained
unclear how these effectors cause phos-
phorylation of RIN4 and whether phos-
phorylation of RIN4 is what activates
RPM1. Two papers in this issue by Chung
et al. (2011) and Liu et al. (2011) now
answer these long-standing questions.
The answer to the first question appears
to be ‘‘indirectly,’’ while the answer to
the second question is ‘‘yes.’’
Prior work had produced a crystal
structure of AvrB bound to a small
peptide from RIN4 (Desveaux et al.,
2007). This structure revealed that AvrB
contained an ATP-binding pocket and
further suggested that a specific threo-
nine residue on RIN4 was likely phosphor-
ylated by AvrB if AvrB possessed kinase
activity. Despite the best efforts of
multiple labs, however, no one has been
able to demonstrate kinase activity for
AvrB in vitro. Chung et al. took the next
logical step and modified the putatively
phosphorylated threonine residue (T166),
changing it to alanine to prevent phos-
phorylation, and to aspartate to mimic
phosphorylation. Consistent with RIN4
T166 playing a central role in the activa-
tion of RPM1, the T166A substitution
completely abrogated activation of88 Cell Host & Microbe 9, February 17, 2011RPM1 by AvrB. More importantly, the
T166D substitution activated RPM1 in
the absence of pathogen effectors,
demonstrating that this minor modifica-
tion of RIN4 was sufficient to trigger
RPM1 signaling. Finally, using an anti-
body raised against a RIN4 peptide con-
taining phosphorylated T166, Chung
et al. were able to show that T166 does
indeed become phosphorylated in the
presence of both AvrB and AvrRpm1.
A perhaps surprising result in the Chung
et al. work is that the T166A substitution
has only a very minor impact on recogni-
tion of AvrRpm1 by RPM1. This observa-
tion indicates that while phosphorylation
of T166 may be sufficient to activate
RPM1, it is not the only way to do so. It
also suggests that AvrRpm1 induces
modification of other RIN4 residues in
addition to T166. What these residues
are remains to be determined.
The Liu et al. paper extends the findings
of Chung et al. by identifying a host kinase,
RPM1-induced protein kinase 1 (RIPK1)
that phosphorylates RIN4 on T166 and is
bound by AvrB. RIPK1 belongs to the
receptor-like cytoplasmic kinase (RLCK)
family, of which several have now been
shown to play a role in plant innate immu-
nity, including the Arabidopsis BIK1 and
PBS1 proteins and the tomato Pto protein
(DeYoung and Innes, 2006; Zhang et al.,
2010). Significantly, all of these RLCKs
are targeted by various P. syringae effec-
tors, and PBS1 and Pto are both involvedª2011 Elsevier Inc.in activating NLRs (DeYoung and Innes,
2006; Zhang et al., 2010).
RIPK became of interest to Liu et al.
when it was identified by mass spectrom-
etry as part of a RIN4-containing protein
complex, which they purified after
activation by AvrRpm1. RIPK knockout
mutants displayed enhanced resistance
to virulent P. syringae strains, while over-
expression lines displayed enhanced
susceptibility, indicating that RIPK func-
tions asa negative regulator of basal resis-
tance pathways, as does RIN4. The phys-
ical association of RIN4with RIPK1 led Liu
et al. to test whether RIN4was a substrate
of RIPK in vitro, and they found that RIPK
phosphorylated RIN4 at three positions,
T21, S160, and T166. Similar to the
approach taken by Chung et al., Liu et al.
substituted a phosphomimetic residue
(aspartate) at each of these positions and
assessed whether the modified RIN4
protein could activate RPM1 in the
absence of effectors. Consistent with the
results of Chung et al., the triply
substituted RIN4 activated RPM1.
Based on these data, Liu et al. hypoth-
esized that AvrBmight function by binding
to RIPK and enhancing the kinase activity
of RIPK and/or its specificity for RIN4,
thus leading to enhanced phosphoryla-
tion of RIN4 (Figure 1A). The obvious
question then becomes whether RIPK is
required for AvrB-mediated phosphoryla-
tion of RIN4 and for activation of RPM1.
The somewhat disappointing answer is
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Previews‘‘only partially.’’ The RIPK knockout
mutant shows a reproducible reduction
in RIN4 phosphorylation in response to
AvrB, but no reduction in response to
AvrRpm1, as assessed with an anti-phos-
pho-T166 antibody. Consistent with this
result, growth of a P. syringae strain ex-
pressing AvrB is only slightly enhanced
in the ripK knockout, and the number of
cells undergoing RPM1-induced cell
death in response to this strain is slightly
reduced. The authors speculate that the
likely reason for these relatively modest
effects is functional redundancy with
other RLCK family members. Unfortu-
nately, the large number of similar family
members precludes an easy test of this
hypothesis.
Another puzzling result is that AvrB and
RIPK appear to compete for the same
binding site on RIN4; when all three
proteins are coexpressed, only AvrB
immunoprecipitates with RIN4. It thus
remains a possibility that AvrB phosphor-
ylates RIN4 directly. Since the authors
also show that RIPK can phosphorylateAvrB, one plausible model is that RIPK
functions to phosphorylate AvrB, which
then activates AvrB kinase activity
(Figure 1B). The reduced phosphorylation
of RIN4 in the ripK mutant background
would then be the result of reduced AvrB
activation.
Regardless of which model ultimately
proves correct, the work of Chung et al.
and Liu et al. have clearly established
that NLR proteins can be activated by
phosphorylation of other associated host
proteins. It will be of interest to see how
widespread this mechanism is among
other plant and animal NLRs. At a more
mechanistic level, the interesting question
now becomes how phosphorylation of
RIN4 alters its interaction with RPM1,
and how this change leads to activation
of RPM1.ACKNOWLEDGMENTS
R.W.I.’s work on NLRs is funded by the National
Institutes of Health, National Institute of General
Medical Sciences (grant number R01 GM046451).Cell Host & Microbe 9REFERENCES
Chung, E.-H., Cunha, L., Wu, A.-J., Gao, Z., Cher-
kis, K., Afzale, A.J., Mackey, D., and Dangl, J.L.
(2011). Cell Host Microbe 9, this issue, 125–136.
Desveaux, D., Singer, A.U., Wu, A.J., McNulty,
B.C., Musselwhite, L., Nimchuk, Z., Sondek, J.,
and Dangl, J.L. (2007). PLoS Pathog. 3, e48.
DeYoung, B.J., and Innes, R.W. (2006). Nat. Immu-
nol. 7, 1243–1249.
Inohara, N., Chamaillard, M., McDonald, C., and
Nun˜ez, G. (2005). Annu. Rev. Biochem. 74,
355–383.
Liu, J., Elmore, J.M., Lin, Z.-J.D., and Coaker, G.
(2011). Cell Host Microbe 9, this issue, 137–146.
Mackey, D., Holt, B.F., 3rd, Wiig, A., and Dangl,
J.L. (2002). Cell 108, 743–754.
Schroder, K., and Tschopp, J. (2010). Cell 140,
821–832.
Zhang, J., Li, W., Xiang, T., Liu, Z., Laluk, K., Ding,
X., Zou, Y., Gao, M., Zhang, X., Chen, S., et al.
(2010). Cell Host Microbe 7, 290–301.
Zhou, R., Tardivel, A., Thorens, B., Choi, I., and
Tschopp, J. (2010). Nat. Immunol. 11, 136–140.
Zhou, R., Yazdi, A.S., Menu, P., and Tschopp, J.
(2011). Nature 469, 221–225.Evicting the Pneumococcus
from Its Nasopharyngeal LodgingsJames C. Paton1,* and Abiodun D. Ogunniyi1
1Research Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, Adelaide 5005, Australia
*Correspondence: james.paton@adelaide.edu.au
DOI 10.1016/j.chom.2011.01.013
Nasopharyngeal colonization by Streptococcus pneumoniae precedes invasive disease and mediates
community transmission of the pathogen. In this issue,Moffitt et al. (2011) used proteomic analysis to identify
conserved pneumococcal protein vaccine antigens that elicit TH17-dependent responses capable of
preventing such colonization.Streptococcus pneumoniae (the pneu-
mococcus) is one of the foremost bacte-
rial pathogens in humans, causing
massive global morbidity and more than
a million deaths each year. However, it
is essentially a commensal organism,
asymptomatically colonizing the naso-
pharynx of a significant proportion of
the human population, particularly young
children and the elderly. Such carriage
acts as a reservoir for transmission ofthe organism in the community, as well
as a beachhead for subsequent penetra-
tion to otherwise sterile sites, including
the middle ear cavity, lungs, blood,
and brain, resulting in pneumococcal
disease.
Development of effective and afford-
able pneumococcal vaccines has been
a global health priority for many decades.
Vaccines comprising purified capsular
polysaccharides, the dominant pneumo-coccal surface antigens, were licensed
in the late 1970s. However, these suffered
from the shortcoming of poor immunoge-
nicity in high-risk groups (particularly
young children) because the component
polysaccharides are T cell-independent
antigens. Furthermore, the vaccine for-
mulations (initially 14- and later 23-valent)
provided incomplete coverage of the
more than 90 known capsular serotypes
of S. pneumoniae., February 17, 2011 ª2011 Elsevier Inc. 89
